Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After Undergoing Percutaneous Coronary Intervention:The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) - 2 Study
Latest Information Update: 24 Jul 2024
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease; Thrombosis
- Focus Pharmacodynamics
- Acronyms SWAP-AC-2
- 18 Jul 2024 Planned End Date changed from 4 May 2024 to 30 Nov 2025.
- 18 Jul 2024 Planned primary completion date changed from 4 May 2024 to 30 Nov 2025.
- 18 Jul 2024 Status changed from recruiting to active, no longer recruiting.